Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.38 Million ≈ $17.18 Million USD) by net assets (CN¥15.04 Billion ≈ $2.20 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600436 company net worth for the company's overall valuation and market capitalisation.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhangzhou Pientzehuang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 600436 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bollore SA
PA:BOL
|
0.000x |
|
New York Times Company
NYSE:NYT
|
0.095x |
|
Crane Company
NYSE:CR
|
-0.063x |
|
Insurance Australia Group Limited
F:NRM
|
0.010x |
|
Ambuja Cements Limited
NSE:AMBUJACEM
|
0.020x |
|
Akzo Nobel NV
AS:AKZA
|
0.096x |
|
JSW Energy Limited
NSE:JSWENERGY
|
0.159x |
|
AKESO INC. O.N.
F:4RY
|
N/A |
Annual Cash Flow Conversion Efficiency for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2001 to 2025. View Zhangzhou Pientzehuang Pharmaceutical Co (600436) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥15.09 Billion ≈ $2.21 Billion |
CN¥77.03 Million ≈ $11.27 Million |
0.005x | -94.23% |
| 2024-12-31 | CN¥14.84 Billion ≈ $2.17 Billion |
CN¥1.31 Billion ≈ $192.24 Million |
0.089x | -44.15% |
| 2023-12-31 | CN¥13.92 Billion ≈ $2.04 Billion |
CN¥2.21 Billion ≈ $322.90 Million |
0.159x | -72.73% |
| 2022-12-31 | CN¥11.82 Billion ≈ $1.73 Billion |
CN¥6.87 Billion ≈ $1.01 Billion |
0.581x | +1174.64% |
| 2021-12-31 | CN¥10.14 Billion ≈ $1.48 Billion |
CN¥462.27 Million ≈ $67.64 Million |
0.046x | -74.33% |
| 2020-12-31 | CN¥8.26 Billion ≈ $1.21 Billion |
CN¥1.47 Billion ≈ $214.68 Million |
0.178x | +240.83% |
| 2019-12-31 | CN¥6.97 Billion ≈ $1.02 Billion |
CN¥-879.37 Million ≈ $-128.68 Million |
-0.126x | -209.37% |
| 2018-12-31 | CN¥5.31 Billion ≈ $776.67 Million |
CN¥612.31 Million ≈ $89.60 Million |
0.115x | -24.58% |
| 2017-12-31 | CN¥4.43 Billion ≈ $647.55 Million |
CN¥676.93 Million ≈ $99.06 Million |
0.153x | +45.43% |
| 2016-12-31 | CN¥3.75 Billion ≈ $548.85 Million |
CN¥394.54 Million ≈ $57.73 Million |
0.105x | +13.74% |
| 2015-12-31 | CN¥3.30 Billion ≈ $483.38 Million |
CN¥305.51 Million ≈ $44.71 Million |
0.092x | +4.45% |
| 2014-12-31 | CN¥2.99 Billion ≈ $437.14 Million |
CN¥264.50 Million ≈ $38.70 Million |
0.089x | -16.34% |
| 2013-12-31 | CN¥2.59 Billion ≈ $379.33 Million |
CN¥274.34 Million ≈ $40.14 Million |
0.106x | +1.37% |
| 2012-12-31 | CN¥1.56 Billion ≈ $227.63 Million |
CN¥162.40 Million ≈ $23.76 Million |
0.104x | -46.71% |
| 2011-12-31 | CN¥1.19 Billion ≈ $173.99 Million |
CN¥232.95 Million ≈ $34.09 Million |
0.196x | +3.38% |
| 2010-12-31 | CN¥1.08 Billion ≈ $158.60 Million |
CN¥205.41 Million ≈ $30.06 Million |
0.190x | +25.43% |
| 2009-12-31 | CN¥857.19 Million ≈ $125.43 Million |
CN¥129.52 Million ≈ $18.95 Million |
0.151x | +803.81% |
| 2008-12-31 | CN¥752.09 Million ≈ $110.05 Million |
CN¥12.57 Million ≈ $1.84 Million |
0.017x | -78.87% |
| 2007-12-31 | CN¥758.85 Million ≈ $111.04 Million |
CN¥60.04 Million ≈ $8.79 Million |
0.079x | -3.09% |
| 2006-12-31 | CN¥621.09 Million ≈ $90.89 Million |
CN¥50.70 Million ≈ $7.42 Million |
0.082x | -28.12% |
| 2005-12-31 | CN¥608.07 Million ≈ $88.98 Million |
CN¥69.06 Million ≈ $10.11 Million |
0.114x | -37.95% |
| 2004-12-31 | CN¥539.08 Million ≈ $78.88 Million |
CN¥98.67 Million ≈ $14.44 Million |
0.183x | +213.15% |
| 2003-12-31 | CN¥553.59 Million ≈ $81.01 Million |
CN¥32.36 Million ≈ $4.73 Million |
0.058x | -91.42% |
| 2002-12-31 | CN¥154.81 Million ≈ $22.65 Million |
CN¥105.45 Million ≈ $15.43 Million |
0.681x | +51.06% |
| 2001-12-31 | CN¥146.02 Million ≈ $21.37 Million |
CN¥65.84 Million ≈ $9.63 Million |
0.451x | -- |
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemic… Read more